Firocoxib
Firocoxib (INN; brand names Equioxx and Previcox) is a nonsteroidal anti-inflammatory drug of the COX-2 inhibitor (coxib) class, currently approved for use in dogs and horses. Firocoxib was the first COX-2 inhibitor approved by the U.S. Food and Drug Administration for horses.[2] Firocoxib is not intended or approved for use in human medicine.[3]
![]() | |
![]() | |
| Clinical data | |
|---|---|
| Trade names | Equioxx; Previcox |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATCvet code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H20O5S |
| Molar mass | 336.40 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
References
- "New NSAID Equioxx (firocoxib) Approved by USEF". The Horse. July 2, 2007. Retrieved 2008-04-18.
- Equioxx, European Medicines Agency
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

